<DOC>
	<DOCNO>NCT01136551</DOCNO>
	<brief_summary>The purpose study develop oral control release formulation Huperzine A provide optimal pharmacokinetic profile drug enhance safety compliance , possible cure neurodegenerative disorder .</brief_summary>
	<brief_title>Comparative Bioavailability Study Immediate Release Controlled Release Oral Formulations Huperzine A</brief_title>
	<detailed_description />
	<mesh_term>Huperzine A</mesh_term>
	<criteria>1 . Healthy male age 18 35 , inclusive ( ASA = 1 ) 2 . Body weight &gt; 50 kg 3 . Subject BMI le 27 20 4 . Participants able ingest oral medication 5 . The ability understand sign write informed consent form , prior participation willingness comply study requirement 1 . History drug sensitivity drug allergy 2 . History sensitivity egg 3 . Subject BMI le 20 27 4 . Previous participation investigational trial involve administration investigational compound within 1 month prior current study 5 . History alcoholism drug addiction 6 . Any medication take include overthecounter medication herbal product within 14 day commence study drug dose exception vitamin and/or paracetamol . When concomitant medication necessary , review investigator contraindicate , may continue dose frequency study period 7 . History clinically important illness ( ASA &gt; 1 ) ; Disorders condition could affect absorption , distribution , metabolism and/or excretion drug ( e.g . malabsorption , edema , renal hepatic insufficiency ) 8 . Inability relate and/or cooperate investigator 9 . Blood loss donation great 200ml 3 month prior trial 10 . Exhausting physical exercise previous 48 hour drug administration 11 . Subjects smoke use nicotinecontaining product within 6 month prior study entry</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Pharmacokinetic profile control release formulation Huperzine A</keyword>
	<keyword>Bioequivalence Huperzine A IR formulation CR formulation</keyword>
</DOC>